Reasons for patient reluctance to take preventive medications for migraine: Results of the <scp>OVERCOME</scp> ( <scp>US</scp> ) study
This study highlights an important need for patient education, especially as many of these individuals who had never taken medications to prevent migraine reported experiencing ≥15 monthly headache days (25.3%), severe interictal burden (43.3%), and severe migraine-related disability (53.1%). We believe that these results may be of interest to health care providers who see people with migraine and help them better understand and anticipate their patients' educational needs regarding migraine prevention.
Authors
- Helen Hochstetler (ORCID: https://orcid.org/0000-0002-7428-4355)
- Anthony J. Zagar (ORCID: https://orcid.org/0000-0002-8353-6665)
- Betzaida Martinez
- Elizabeth Johnston (ORCID: https://orcid.org/0000-0002-0589-2701)
- Jessica Ailani (ORCID: https://orcid.org/0000-0001-8106-4927)
- Rose Okonkwo (ORCID: https://orcid.org/0000-0001-5015-6458)
- Robert A. Nicholson (ORCID: https://orcid.org/0000-0002-2725-9739)
- Bert B. Vargas
- E. Jolanda Muenzel
- Richard B. Lipton
Institutions
- Albert Einstein College of Medicine (US)
- Montefiore Medical Center (US)
- Eli Lilly (United States) (US)
- Georgetown University (US)
- MedStar Georgetown University Hospital (US)
Publication Details
- Journal
- Headache The Journal of Head and Face Pain
- Published
- 2026-01-06
- DOI
- https://doi.org/10.1111/head.70014
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00